Analysts Set Solventum Co. (NYSE:SOLV) PT at $79.86

Shares of Solventum Co. (NYSE:SOLV) have earned an average rating of “Hold” from the ten research firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $79.86.

Several equities research analysts have weighed in on SOLV shares. Bank of America upped their target price on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. Wells Fargo & Company raised their price target on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. The Goldman Sachs Group boosted their target price on Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a research note on Monday, March 3rd. Morgan Stanley increased their price target on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 5th. Finally, Piper Sandler boosted their price target on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research note on Friday, February 28th.

Institutional Investors Weigh In On Solventum

Several hedge funds have recently added to or reduced their stakes in SOLV. Modus Advisors LLC purchased a new stake in shares of Solventum in the fourth quarter worth about $25,000. Clarity Asset Management Inc. acquired a new position in Solventum in the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC purchased a new stake in Solventum in the 4th quarter worth approximately $26,000. Raiffeisen Bank International AG acquired a new stake in shares of Solventum during the 4th quarter worth approximately $29,000. Finally, Crews Bank & Trust purchased a new position in shares of Solventum during the 4th quarter valued at approximately $32,000.

Solventum Price Performance

NYSE:SOLV opened at $65.02 on Friday. The firm has a market capitalization of $11.25 billion and a price-to-earnings ratio of 23.64. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The business has a 50 day simple moving average of $73.04 and a 200-day simple moving average of $71.60. Solventum has a 1 year low of $47.16 and a 1 year high of $85.92.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.